C. Gregory Peters
Stock Analyst at Raymond James
(4.64)
# 187
Out of 4,902 analysts
205
Total ratings
70.53%
Success rate
13.96%
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterates: Strong Buy | $115 → $120 | $99.05 | +21.15% | 13 | Jul 8, 2025 | |
| HMN Horace Mann Educators | Maintains: Strong Buy | $46 → $49 | $41.30 | +18.64% | 2 | May 15, 2025 | |
| EG Everest Group | Reiterates: Strong Buy | $420 → $410 | $333.10 | +23.09% | 2 | May 6, 2025 | |
| ALL The Allstate Corporation | Reiterates: Strong Buy | $240 → $250 | $193.00 | +29.53% | 24 | May 5, 2025 | |
| HIG The Hartford Insurance Group | Maintains: Outperform | $125 → $135 | $122.43 | +10.27% | 7 | Mar 31, 2025 | |
| MCY Mercury General | Upgrades: Strong Buy | $70 → $80 | $68.19 | +17.32% | 6 | Feb 12, 2025 | |
| MMC Marsh & McLennan Companies | Reiterates: Outperform | $240 → $250 | $211.91 | +17.97% | 17 | Feb 6, 2025 | |
| KMPR Kemper | Maintains: Strong Buy | $75 → $82 | $61.76 | +32.77% | 13 | Dec 26, 2024 | |
| HGTY Hagerty | Downgrades: Underperform | n/a | $10.09 | - | 2 | Dec 26, 2024 | |
| PGR The Progressive Corporation | Upgrades: Outperform | $305 | $246.32 | +23.82% | 20 | Dec 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Strong Buy | $365 → $400 | $305.37 | +30.99% | 10 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $10.90 | +46.79% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $45 → $55 | $54.08 | +1.70% | 8 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $110 | $104.66 | +5.10% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $40 → $45 | $43.14 | +4.32% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $270 → $285 | $275.80 | +3.34% | 8 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $220 → $245 | $261.91 | -6.46% | 7 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $314.13 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $302.19 | -13.96% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $36.76 | -18.38% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $356.18 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $149.02 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $70.17 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $101.51 | -34.00% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.02 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.74 | - | 4 | Feb 1, 2021 |
HealthEquity
Jul 8, 2025
Reiterates: Strong Buy
Price Target: $115 → $120
Current: $99.05
Upside: +21.15%
Horace Mann Educators
May 15, 2025
Maintains: Strong Buy
Price Target: $46 → $49
Current: $41.30
Upside: +18.64%
Everest Group
May 6, 2025
Reiterates: Strong Buy
Price Target: $420 → $410
Current: $333.10
Upside: +23.09%
The Allstate Corporation
May 5, 2025
Reiterates: Strong Buy
Price Target: $240 → $250
Current: $193.00
Upside: +29.53%
The Hartford Insurance Group
Mar 31, 2025
Maintains: Outperform
Price Target: $125 → $135
Current: $122.43
Upside: +10.27%
Mercury General
Feb 12, 2025
Upgrades: Strong Buy
Price Target: $70 → $80
Current: $68.19
Upside: +17.32%
Marsh & McLennan Companies
Feb 6, 2025
Reiterates: Outperform
Price Target: $240 → $250
Current: $211.91
Upside: +17.97%
Kemper
Dec 26, 2024
Maintains: Strong Buy
Price Target: $75 → $82
Current: $61.76
Upside: +32.77%
Hagerty
Dec 26, 2024
Downgrades: Underperform
Price Target: n/a
Current: $10.09
Upside: -
The Progressive Corporation
Dec 26, 2024
Upgrades: Outperform
Price Target: $305
Current: $246.32
Upside: +23.82%
Dec 5, 2024
Upgrades: Strong Buy
Price Target: $365 → $400
Current: $305.37
Upside: +30.99%
Nov 12, 2024
Maintains: Outperform
Price Target: $15 → $16
Current: $10.90
Upside: +46.79%
Nov 5, 2024
Maintains: Strong Buy
Price Target: $45 → $55
Current: $54.08
Upside: +1.70%
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $104.66
Upside: +5.10%
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $43.14
Upside: +4.32%
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $275.80
Upside: +3.34%
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $261.91
Upside: -6.46%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $314.13
Upside: -
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $302.19
Upside: -13.96%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $36.76
Upside: -18.38%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $356.18
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $149.02
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $70.17
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $101.51
Upside: -34.00%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $6.02
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.74
Upside: -